Pharmala Biotech 研发与监管里程碑达2333万美元,其中2000万美元与FDA批准挂钩

美股速递
Jul 21

Pharmala Biotech 宣布了一系列研发与监管相关的里程碑付款,总额最高可达2333万美元。值得注意的是,其中高达2000万美元的款项与获得美国食品药品监督管理局的最终批准直接相关。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10